Ardelyx, Inc. (NASDAQ:ARDX – Get Rating)’s stock price dropped 5.9% during trading on Monday . The company traded as low as $4.31 and last traded at $4.34. Approximately 2,561,322 shares traded hands during mid-day trading, a decline of 63% from the average daily volume of 6,903,685 shares. The stock had previously closed at $4.61. Wall […]
StockNews.com upgraded shares of Ardelyx (NASDAQ:ARDX – Get Rating) from a hold rating to a buy rating in a report issued on Wednesday. Separately, Wedbush raised their price target on shares of Ardelyx from $6.00 to $7.00 and gave the company an outperform rating in a report on Monday, April 17th. Ardelyx Stock Performance NASDAQ […]
Fiera Capital Corp increased its stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Rating) by 29.2% in the 4th quarter, Holdings Channel reports. The firm owned 5,189,157 shares of the biopharmaceutical company’s stock after purchasing an additional 1,172,602 shares during the period. Fiera Capital Corp’s holdings in Amicus Therapeutics were worth $63,360,000 at […]
Ardelyx, Inc. (NASDAQ:ARDX – Get Rating) shares gapped down before the market opened on Thursday . The stock had previously closed at $4.68, but opened at $4.43. Ardelyx shares last traded at $4.46, with a volume of 3,157,588 shares traded. Analyst Ratings Changes ARDX has been the subject of a number of research reports. Wedbush […]
Ardelyx, Inc. (NASDAQ:ARDX – Get Rating) – Equities researchers at Wedbush issued their Q2 2024 EPS estimates for Ardelyx in a note issued to investors on Thursday, May 4th. Wedbush analyst L. Chico expects that the biopharmaceutical company will post earnings of $0.01 per share for the quarter. Wedbush has a “Outperform” rating and a […]